9. Overt Thyroid Dysfunction During Treatment of Hepatitis C Patients with Interferon and Ribavirin
Nazir Ahmad1, Jawed Akhtar Samo2 and Hammad-Ur-Rehman Bhatti3
ABSTRACT
Objective: To find out the thyroid dysfunctions during treatment hepatitis C patients with Interferon and Ribavirin.
Study Design: Observational / descriptive study
Place and Duration of Study: This study was carried out at the Teaching Hospital, Ghazi Khan Medical College, DG Khan from April 2015 to January 2016.
Patients and Methods: Fifty patients of chronic HCV were enrolled.
Results: Out of 50 treated patients 35 were female and 15 were male. Fifteen (15%) patients developed thyroid dysfunction and out of these 15 patients (11 female [73.3%] and 4 male [26.7%]).Ten (66.6%) out of 15 patients developed hypothyroidism and 5(33.3%) out of 15 patients developed hyperthyroidism. Seven (70%) out of 10 patients who developed hypothyroidism needed levothyroxine therapy. Two (40%) out of 5 patients who developed hyperthyroidism needed carbimazol therapy for their symptoms and disease control. All patients completed hepatitis C treatment with combined Peg-Interferon Alpha-2a and Ribavirin therapy.
Conclusion: The involvement between thyroid dysfunction in hepatitis C individuals and management with IFN-alpha and RIBA.
Key Words: Interferon Alpha-2a, Ribavirin, Chronic hepatitis C
Citation of article: Ahmad N, Samo JA, Bhatti HR. Overt Thyroid Dysfunction during Treatment of Hepatitis C Patients with Interferon and Ribavirin. Med Forum 2016;27(5):30-32.